Indivior sinks as settlement confirmed
0 mins. to read
FTSE 250 pharmaceuticals firm Indivior (LON:INDV) saw its share price drop by 1.79% to 120.80p (as of 11:55 GMT) after a US federal court approved the agreement between the firm and the Department of Justice. Under the terms of the agreement, the company will pay $600 million over seven years and all charges brought by grand jury due to a subsidiary’s false statements will be dismissed.
Management said they were pleased to put this matter behind them and to allow the company to move ahead with certainty.
Comments (0)